Centogene launches rare and neurodegenerative disease biodata network

Cambridge, mass. and rostock, germany and berlin, nov. 03, 2022 (globe newswire) -- centogene n.v. (nasdaq: cntg), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the global launch of its biodata network, a portfolio of data-driven partnering solutions, including biodata licenses and insight reports, for biopharma and research institutions.
CNTG Ratings Summary
CNTG Quant Ranking